A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

NCT02120898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

467

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Imiquimod
DRUG: Zyclara®
DRUG: Vehicle Cream

Sponsor

Actavis Inc.